Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Launches New Multiplex PCR System

NEW YORK, Feb 22 – Stratagene has introduced a Mx4000 PCR instrument system designed specifically for multiplexed QPCR, the company said Thursday.

The system, which supports all available fluorescent dyes and performs real-time PCR, is the first of its kind, the company said. It is designed to perform PCR for allelic discrimination, mutational analysis, and quantification of single or multiplexed targets. The system also has software that allows users to view real-time amplification plots while a PCR experiment is in progress.

After the experiment is complete, the software allows users to formulate data amplification plots, scatter plots, threshold cycle values, and fluorescence intensity screens. Users can also analyze melting curves and multiple standard curves on the same plot, and evaluate selected sample wells independently.

"Quantitative PCR has rapidly become one of the most important technologies for genotyping and gene expression analysis,” Alex Szabo, Stratagene's vice president of marketing, said in a statement. “The ability to perform these assays under true multiplexed conditions greatly increases their reliability while reducing costs to researchers. Stratagene is proud to introduce an instrument that establishes a new benchmark of performance in this field."

The company did not disclose pricing information for the system.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.